Luke Beshar
Executive Vice Presiden
management
Trillium Therapeutics
Canada
Biography
Luke Beshar served as Executive Vice President and Chief Financial Officer of NPS Pharmaceuticals from 2007 to 2015. In this role he was responsible for financial management, investor relations, information technology, technical operations, supply-chain management, facilities, project management, contracts & outsourcing and stategic and alliance management. Mr. Beshar has utilized his 30 years of experience and strategic and financial expertise to help transform NPS into a global biopharmaceutical company that is bringing innovative therapies to patients with rare diseases around the world. Under his financial leadership, NPS secured approximately $400 million of capital and its market capitalization increased from $180 million to more than $3 billion. Prior to joining NPS, Mr. Beshar served as Executive Vice President and Chief Financial Officer of Cambrex Corporation, a global life sciences company. At Cambrex, his accomplishments included raising approximately $600 million of new capital, building a high performance global finance team, and leading a process of evaluating strategic alernatives, which resulted in the sale of non-strategic operations for $460 million and an $11 per share special dividend to shareholders. Mr. Beshar began his career with Arthur Andersen & Co. and is a certified public accountant. He obtained his bachelor's degree in Accounting and Finance from Michigan State University and is a graduate of The Executive Program at the Darden Graduate School of Business at the University of Virgina.
Research Interest
financial management, investor relations, information technology, technical operations, supply-chain management, facilities, project management, contracts & outsourcing and stategic and alliance management.